NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

Cytogenetics and European Leukemia Net (ELN) genetic classification predict patients at increased risk of relapse in acute myeloid leukemia (AML) except in the intermediate risk group for which further prognostic determinants are required. We have previously shown that Natural Killer (NK) cell defec...

Descripción completa

Detalles Bibliográficos
Autores principales: Chretien, Anne-Sophie, Fauriat, Cyril, Orlanducci, Florence, Rey, Jerome, Borg, Gaelle Bouvier, Gautherot, Emmanuel, Granjeaud, Samuel, Demerle, Clemence, Hamel, Jean-François, Cerwenka, Adelheid, von Strandmann, Elke Pogge, Ifrah, Norbert, Lacombe, Catherine, Cornillet-Lefebvre, Pascale, Delaunay, Jacques, Toubert, Antoine, Arnoulet, Christine, Vey, Norbert, Olive, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564787/
https://www.ncbi.nlm.nih.gov/pubmed/28548938
http://dx.doi.org/10.18632/oncotarget.17747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564787/
https://www.ncbi.nlm.nih.gov/pubmed/28548938
http://dx.doi.org/10.18632/oncotarget.17747

Ejemplares similares